Exact Mass: 484.43656080000005
Exact Mass Matches: 484.43656080000005
Found 375 metabolites which its exact mass value is equals to given mass value 484.43656080000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3beta-Acetoxy-19alpha-hydroxy-12-ursene
3beta-Acetoxy-19alpha-hydroxy-12-ursene is found in pomes. 3beta-Acetoxy-19alpha-hydroxy-12-ursene is a constituent of Pyrus communis (pear). Constituent of Pyrus communis (pear). 3beta-Acetoxy-19alpha-hydroxy-12-ursene is found in pomes.
DG(8:0/18:0/0:0)
DG(8:0/18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/18:0)
DG(8:0/0:0/18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/i-18:0/0:0)
DG(8:0/i-18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/i-18:0)
DG(8:0/0:0/i-18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/16:0/0:0)
DG(10:0/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/16:0)
DG(10:0/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/i-16:0/0:0)
DG(10:0/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/i-16:0)
DG(10:0/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/14:0/0:0)
DG(12:0/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/14:0)
DG(12:0/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/14:0/0:0)
DG(i-12:0/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/14:0)
DG(i-12:0/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/i-14:0/0:0)
DG(i-12:0/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/i-14:0)
DG(i-12:0/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/i-14:0/0:0)
DG(12:0/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/i-14:0)
DG(12:0/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/13:0/0:0)
DG(13:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/13:0)
DG(13:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/13:0/0:0)
DG(i-13:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/13:0)
DG(i-13:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/i-13:0/0:0)
DG(a-13:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/i-13:0)
DG(a-13:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/a-13:0/0:0)
DG(i-13:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/a-13:0)
DG(i-13:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/13:0/0:0)
DG(a-13:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/13:0)
DG(a-13:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/i-13:0/0:0)
DG(i-13:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/i-13:0)
DG(i-13:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/i-13:0/0:0)
DG(13:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/i-13:0)
DG(13:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/a-13:0/0:0)
DG(13:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/a-13:0)
DG(13:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/a-13:0/0:0)
DG(a-13:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/a-13:0)
DG(a-13:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(14:0/12:0/0:0)
DG(14:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(14:0/0:0/12:0)
DG(14:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/12:0/0:0)
DG(i-14:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/0:0/12:0)
DG(i-14:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/i-12:0/0:0)
DG(i-14:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/0:0/i-12:0)
DG(i-14:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(14:0/i-12:0/0:0)
DG(14:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(14:0/0:0/i-12:0)
DG(14:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/10:0/0:0)
DG(16:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/10:0)
DG(16:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/10:0/0:0)
DG(i-16:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/10:0)
DG(i-16:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:0/8:0/0:0)
DG(18:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:0/0:0/8:0)
DG(18:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-18:0/8:0/0:0)
DG(i-18:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-18:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-18:0/0:0/8:0)
DG(i-18:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Me ester-Eburicoic acid|Methyl eburicoate|Methyl-eburicoat
(2E)-{(20S)-20-[formyl(methyl)amino]-5alpha-pregnan-3beta-yl}-3,4-dimethylpent-2-enamide|hookerianamide-D
C31H52N2O2 (484.40285719999997)
(20RS)-3beta-acetoxylupan-29-al|(20Xi)-3beta-acetoxy-lupan-29-al|3beta-Acetoxylupan-2-al
(4aR)-8c-Hydroxy-10c-acetoxy-2.2.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14bcH)-Delta14-eicosahydro-picen|3-O-acetyldaturadiol|3beta-Acetoxy-oleanen-(12)-ol-(6beta)|acetic acid-(6beta-hydroxy-oleanen-(12)-yl-(3beta)-ester)|daturadiol 3-monoacetate|Essigsaeure-(6beta-hydroxy-oleanen-(12)-yl-(3beta)-ester)
3alpha-acetoxy-25-hydroxylanosta-8,23-diene|3??-Acetoxy-25-hydroxylanosta-8,23-diene
Stigmasteroltrimethylsilylether|Trimethylsilylderivat v. Stigmasterol
D:A-Friedooleanan-26-al, 3-(acetyloxy)-, (3.beta.)-
dammara-20,25-dien-3beta-acetoxy-17alpha-ol|Dammara-20,25-diene-3,17-diol-(3beta,17alpha)-form-3-Ac
3beta-acetoxy-fern-9(11)-en-19beta-ol|3beta-acetoxyfern-9(11)-en-19beta-ol
25-Acetoxy-friedelan-3-on|25-acetoxy-friedelan-3-one|3-oxo-D:A-friedo-oleanan-25-yl-acetate|3-oxo-D:A-friedooleanan-25-yl acetate
9,19-Cyclolanostan-24-one, 3-(acetyloxy)-, (3.beta.)-
(3beta)-3-hydroxy-30-propylhopan-31-one|(5R)-5-[(3R,3aS,5aR,5bR,7aR,9S,11aR,13aR,13bS)-eicosahydro-9-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-1H-cyclopenta[a]chrysen-3-yl]hexan-3-one
canophyllol acetate|Canophyllol-acetat|canophyllyl acetate
28-O-acetylerythrodiol|3-hydroxyolean-12-en-28-yl acetate
(4aS)-5c-Hydroxy-10c-acetoxy-2.2.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14bcH)-Delta14-eicosahydro-picen|3beta-Acetoxy-oleanen-(12)-ol-(16beta)|3beta-O-acetyl-16beta-hydroxyolean-12-ene|acetic acid-(16beta-hydroxy-oleanen-(12)-yl-(3beta)-ester)|Essigsaeure-(16beta-hydroxy-oleanen-(12)-yl-(3beta)-ester)
3beta-acetoxy-6beta-hydroxy-olean-18-ene|6beta-hydroxyolean-18-en-3beta-yl acetate
3beta-Acetoxylup-20(29)-en-11beta-ol|3beta-acetyloxylup-20(29)-ene-11beta-ol
30-hydroxy lupenyl acetate|30-hydroxy,3-acetyl lupeol|3beta-acetoxy-30-hydroxy-lup-20(29)-en|3beta-acetoxy-30-hydroxylup-20(29)-ene|3beta-acetoxylup-20(29)-en-30-ol|acetic acid-[30-hydroxy-lupen-(20(29))-yl-(3beta)-ester]|lupenyl acetate
3beta-acetoxy-25-hydroxydammara-20,23-diene|3??-Acetoxy-25-hydroxydammara-20,23-diene
3beta-acetoxytaraxaster-20-en-30-al|taraxa-30-al-3beta-yl acetate
3beta-methoxy-25-methyl-24-methylenelanost-9(11)-en-21-ol
CID 137796353
3beta-Acetoxy-19alpha-hydroxy-12-ursene
Heneicosanylserotonin
C31H52N2O2 (484.40285719999997)
Ethyl Lansiolate
A triterpenoid that is the ethyl ester of lansiolic acid. It has been isolated from the twigs of Lansium domesticum.
Silane, trimethyl[[(3beta)-stigmasta-5,24(28)-dien-3-yl]oxy]-
(3-Carboxy-2-docosanoyloxypropyl)-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(19-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(17-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(11-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(20-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(9-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(8-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(4-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(16-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(6-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(12-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(10-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(18-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(7-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(14-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(13-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(5-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(15-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(3-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
3beta-Acetoxy-15alpha-hydroxy-22(29)-hopene
A hopanoid that is hop-22(29)-ene substituted by an acetoxy group at position 3 and a hydroxy group at position 15 (the 3beta,15alpha-stereoisomer). It has been isolated from Hypocrella species.
(1-Hydroxy-3-octanoyloxypropan-2-yl) octadecanoate
Ditridecanoic acid 3-hydroxy-1,2-propanediyl ester
(1-Dodecanoyloxy-3-hydroxypropan-2-yl) tetradecanoate
(2E,6E,10E)-1-(2alpha-Isopropyl-5beta-methylcyclohexoxyacetyloxy)-14-isopropenyl-3,7,11-trimethylcyclotetradecatriene
(1-Hydroxy-3-nonanoyloxypropan-2-yl) heptadecanoate
(1-Hydroxy-3-undecanoyloxypropan-2-yl) pentadecanoate
3beta-Acetoxy-9alpha,11alpha-epoxy-5alpha-lanost-7-ene
[(2S)-3-hydroxy-2-undecanoyloxypropyl] pentadecanoate
(1-Heptanoyloxy-3-hydroxypropan-2-yl) nonadecanoate
(1-Hydroxy-3-propanoyloxypropan-2-yl) tricosanoate
(1-Hydroxy-3-pentanoyloxypropan-2-yl) henicosanoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] pentadecanoate
[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] octadecanoate
(3S,4R,9R,11S)-3-methoxy-4-methylnonacosane-9,11-diol
diacylglycerol 26:0
A diglyceride in which the two acyl groups contain a total of 26 carbons and 0 double bonds.
TG(26:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
SiE(4:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1r,3r,6s,7s,8r,11r,12s,15r,16r)-15-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
9-isopropyl-6,13,14,18,18-pentamethyl-20-oxahexacyclo[17.2.2.0¹,¹⁷.0²,¹⁴.0⁵,¹³.0⁶,¹⁰]tricosan-8-yl acetate
(3s,4ar,6ar,6bs,8as,11r,12s,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl acetate
(3s,4r,4as,6as,6bs,8ar,12ar,12bs,14as,14bs)-6b-formyl-4,4a,8a,11,11,12b,14a-heptamethyl-hexadecahydropicen-3-yl acetate
(3r,3ar,5ar,5br,7ar,9s,11as,13s,13as,13br)-9-hydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-13-yl acetate
12-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
1-(1-hydroxy-6-methylhept-5-en-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
{[(1r,3ar,3br,7r,9as,9br,11ar)-1-[(2s,3z,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}trimethylsilane
6-methoxy-15-(4-methoxy-6-methyl-5-methylideneheptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane
15-[4-(3,3-dimethyloxiran-2-yl)butan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
11-formyl-4,4,6a,6b,8a,12,14b-heptamethyl-hexadecahydro-1h-picen-3-yl acetate
(3s,4ar,6ar,8as,12as,12bs,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,11,11,12b,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl acetate
8-hydroxy-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl acetate
(2,2,4a,6a,8a,9,14a-heptamethyl-10-oxo-tetradecahydro-1h-picen-12b-yl)methyl acetate
1-(6-hydroxy-6-methylhepta-1,4-dien-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
1-hydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,6-dien-2-yl)-dodecahydrocyclopenta[a]phenanthren-7-yl acetate
(4r,4ar,6as,6br,8as,10s,12ar,12bs,14bs)-10-hydroxy-2,2,4a,6a,6b,9,9,12a-octamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl acetate
(1r,3ar,5ar,5br,7as,9r,11r,11ar,11bs,13ar,13br)-9-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-11-yl acetate
(1r,2r,5s,8s,9r,10r,11r,14r,15s,18s,20r)-8-hydroxy-2,5,8,9,15,19,19-heptamethylhexacyclo[12.8.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-18-yl acetate
(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(5r)-5-hydroxy-6-methylhepta-1,6-dien-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(1r,3ar,5ar,5br,7as,9r,11r,11ar,11bs,13ar,13br)-11-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
21α-hydroxyserrat-14-en-3β-yl acetate
{"Ingredient_id": "HBIN003544","Ingredient_name": "21\u03b1-hydroxyserrat-14-en-3\u03b2-yl acetate","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "CC(=O)OC1CCC2(C3CCC4C(=CCC5C4(CCC(C5(C)C)O)C)CC3(CCC2C1(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10704","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
21β-hydroxyserrat-14-en-3β-yl acetate
{"Ingredient_id": "HBIN003560","Ingredient_name": "21\u03b2-hydroxyserrat-14-en-3\u03b2-yl acetate","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10705","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-1-o-heptacosanoyl glycerol
{"Ingredient_id": "HBIN006570","Ingredient_name": "(2s)-1-o-heptacosanoyl glycerol","Alias": "NA","Ingredient_formula": "C30H60O4","Ingredient_Smile": "CCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9410","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-acetoxy-19(29)-taraxasten-20α-ol
{"Ingredient_id": "HBIN008139","Ingredient_name": "3\u03b2-acetoxy-19(29)-taraxasten-20\u03b1-ol","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "283","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-acetoxy-25-hydroxydammara-20,23-diene
{"Ingredient_id": "HBIN008143","Ingredient_name": "3\u03b2-acetoxy-25-hydroxydammara-20,23-diene","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "212","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-acetoxy-25-hydroxylanosta-8,23-diene
{"Ingredient_id": "HBIN008144","Ingredient_name": "3\u03b2-acetoxy-25-hydroxylanosta-8,23-diene","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "228","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-hydroxyserrat-14-en-21α-yl acetate
{"Ingredient_id": "HBIN008261","Ingredient_name": "3\u03b2-hydroxyserrat-14-en-21\u03b1-yl acetate","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "CC(=O)OC1CCC2(C3CCC4C(CCC5C4(CCC(C5(C)C)O)C)(CC3=CCC2C1(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10703","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acetylmyricadiol
{"Ingredient_id": "HBIN014484","Ingredient_name": "acetylmyricadiol","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "CC(=C)C(=O)OC1CC23C(O2)CC(COC3O)C4C(O4)C5C1C(=C)C(=O)O5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14156","TCMID_id": "471","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
betulin-3-acetate
{"Ingredient_id": "HBIN018375","Ingredient_name": "betulin-3-acetate","Alias": "NA","Ingredient_formula": "C32H52O3","Ingredient_Smile": "CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C)C)CO","Ingredient_weight": "484.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2332","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "479957","DrugBank_id": "NA"}
(1r,3ar,3br,5ar,7s,9ar,9br,11as)-1-hydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,6-dien-2-yl)-dodecahydrocyclopenta[a]phenanthren-7-yl acetate
(1r,3ar,7r,9as,11ar)-1-[(2r)-1-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(1r,3ar,5ar,5br,7ar,9s,11as,11br,12s,13ar,13br)-12-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
9-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-11-yl acetate
(2,2,6a,8a,9,12b,14a-heptamethyl-10-oxo-tetradecahydro-1h-picen-4a-yl)methyl acetate
(3r,3ar,5ar,5br,7ar,9s,11as,13r,13as,13br)-13-hydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate
19-hydroxy-1,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate
[(4ar,6ar,6br,8as,9r,12ar,12br,14as,14br)-2,2,4a,6a,8a,9,14a-heptamethyl-10-oxo-tetradecahydro-1h-picen-12b-yl]methyl acetate
14-hydroxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl acetate
(4z,27e,29r)-29-hydroxy-18-methylhentriaconta-4,27-dien-2,30-diynoic acid
(3r,5s)-5-[(1s)-1-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-tert-butyloxolan-2-one
5-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
[(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4a-yl]methyl acetate
(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-{4-[(2r)-3,3-dimethyloxiran-2-yl]but-1-en-2-yl}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(3s,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(1r,3ar,5ar,5br,7s,7ar,9s,11ar,11br,13ar,13br)-7-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(1r,3as,3br,5ar,7r,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(2e)-n-[(3s,6s,8s,11r,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-1(18)-en-6-yl]-2-methylbut-2-enimidic acid
C31H52N2O2 (484.40285719999997)
(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methyl-5-oxoheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
7-methoxy-1-(4-methoxy-6-methyl-5-methylideneheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}trimethylsilane
(3s,4ar,5r,6ar,6br,8as,12s,12ar,12br,14ar,14br)-5-hydroxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,12,12a,12b,13,14,14a-tetradecahydro-1h-picen-3-yl acetate
3a,6,6,9a,11a-pentamethyl-1-(6-methyl-5-methylideneheptan-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
8-hydroxy-2,5,8,9,15,19,19-heptamethylhexacyclo[12.8.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-18-yl acetate
(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2s,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
3-tert-butyl-5-(1-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)oxolan-2-one
(10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4a-yl)methyl acetate
1-hydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate
6b-formyl-4,4a,8a,11,11,12b,14a-heptamethyl-hexadecahydropicen-3-yl acetate
1-[2,5-dimethyl-5-(2-methylbutan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
7-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(4ar,4br,5as,6ar,6br,9s,10ar,12ar,12bs,14ar)-3,3,6b,10,10,12a,12b,14a-octamethyl-tetradecahydro-1h-piceno[13,12b-b]oxiren-9-yl acetate
8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl acetate
(3s,3as,5s,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-5-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(1s,6s,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-1,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate
n-{9a,11a-dimethyl-1-[1-(n-methylformamido)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}-n,3,4-trimethylpent-2-enamide
C31H52N2O2 (484.40285719999997)
[(4as,6as,6br,10s,12ar,12br,14br)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4a-yl]methyl acetate
(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(4e)-6-hydroxy-6-methylhepta-1,4-dien-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
3a,5a,5b,8,8,11a-hexamethyl-1-(1-oxopropan-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(5r)-5-[(3r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-9-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]hexan-3-one
(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-(3-hydroxyprop-1-en-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(6z,12s,14s,23z,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-6,23-dien-18-ol
1-(5,6-dimethylhept-6-en-2-yl)-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
1-(5-hydroxy-6-methylhepta-1,6-dien-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
5-hydroxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,12,12a,12b,13,14,14a-tetradecahydro-1h-picen-3-yl acetate
(3s,6r,8s,11r,12s,15s,16r,19r,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl acetate
(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-[(2s)-1-oxopropan-2-yl]-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(1r,3ar,5ar,7s,9as,11ar)-7-methoxy-1-[(2r,4s)-4-methoxy-6-methyl-5-methylideneheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
(3s,6ar,6bs,8as,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(1s,2s,5r,6s,8r,9r,10s,13r,14r,17r,19s)-9-isopropyl-6,13,14,18,18-pentamethyl-20-oxahexacyclo[17.2.2.0¹,¹⁷.0²,¹⁴.0⁵,¹³.0⁶,¹⁰]tricosan-8-yl acetate
(1s,3s,4s,6s,8s,11r,12s,15r,16r)-6-hydroxy-7,7,12,16-tetramethyl-15-[(2s)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-4-yl acetate
4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[17.3.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl acetate
(2e,10z)-2-[(6z,9z)-pentadeca-6,9-dien-1-yl]nonadeca-2,10-dienal
(1s,3ar,3br,5ar,9ar,9br,11ar)-1-[(2s,5r)-2,5-dimethyl-5-(2-methylbutan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
15-(6-hydroxy-6-methylhept-4-en-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
(3r,3ar,5ar,5br,7s,7as,11ar,11br,13ar,13br)-3-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-3-(prop-1-en-2-yl)-tetradecahydro-1h-cyclopenta[a]chrysen-7-yl acetate
15-(5-hydroxy-6-methylhept-6-en-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
8a-(hydroxymethyl)-4,4,6a,11,11,12b,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl acetate
3,3,6b,10,10,12a,12b,14a-octamethyl-tetradecahydro-1h-piceno[13,12b-b]oxiren-9-yl acetate
(1s,3r,3ar,5ar,5br,7ar,9s,11as,13as,13br)-1-hydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate
(6s,28e,30r)-dotriacont-28-en-2,4,31-triyne-1,6,30-triol
(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r)-4-[(2r)-3,3-dimethyloxiran-2-yl]butan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
11-(hydroxymethyl)-4,4,6a,8a,11,12b,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl acetate
8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl acetate
(2e,10z,13z)-2-[(6z)-pentadec-6-en-1-yl]nonadeca-2,10,13-trienal
(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(3s,4as,6ar,6br,8as,12bs,14as,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl acetate
(1r,3as,3br,5ar,7r,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylhept-6-en-2-yl]-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
5-{9-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl}hexan-3-one
(3s,8s,11r,15s,19r,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl acetate
(1r,3as,3bs,5ar,9as,11ar)-1-[(2r,5s)-5-methoxy-5,6,6-trimethylheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-7-one
9-hydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-13-yl acetate
(1s,3r,6s,8r,11s,12s,15r,16r)-6-methoxy-15-[(2r,4s)-4-methoxy-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane
6-hydroxy-7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-4-yl acetate
15-(5-ethyl-6-methylheptan-2-yl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl acetate
1-(3-hydroxyprop-1-en-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
1-(5-methoxy-5,6,6-trimethylheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-7-one
(3r,4ar,6ar,8ar,11s,12ar,12bs,14ar,14br)-11-(hydroxymethyl)-4,4,6a,8a,11,12b,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl acetate
(27e)-17-methylhentriacont-27-en-2,4,30-triyne-1,6,29-triol
11-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(1r,4r,5r,8r,10s,13r,14r,17r,18r,19r)-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[17.3.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl acetate
n-(1-amino-13-carbamimidamido-5-hydroxytridecan-4-yl)-9-carbamimidamidononanimidic acid
C24H52N8O2 (484.42130119999996)
(1r,3as,3br,5ar,7r,9ar,9bs,11ar)-1-[(2r,4e)-5,6-dimethylhept-4-en-2-yl]-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
13-hydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate
5-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
n-{15-[1-(dimethylamino)ethyl]-3-hydroxy-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-1(18)-en-6-yl}-2-methylbut-2-enimidic acid
C31H52N2O2 (484.40285719999997)
(1s,3as,5ar,7s,9ar,9br,11as)-1-[(2r,4z)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
1-(5,6-dimethylheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r,4z)-6-hydroxy-6-methylhept-4-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
1-(5,6-dimethylhept-4-en-2-yl)-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(3s,4ar,6ar,6bs,8ar,12ar,14s,14ar,14bs)-14-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(1s,3as,5as,7r,9as,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r,5r)-5-hydroxy-6-methylhept-6-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
1-[4-(3,3-dimethyloxiran-2-yl)but-1-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
10-hydroxy-2,2,4a,6a,6b,9,9,12a-octamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl acetate
(3r,4ar,6ar,6br,8r,8as,12s,12ar,12br,14ar,14br)-8-hydroxy-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl acetate
(3s,4ar,6ar,6br,8ar,11r,12s,12ar,12br,14ar,14br)-11-formyl-4,4,6a,6b,8a,12,14b-heptamethyl-hexadecahydro-1h-picen-3-yl acetate
7,7,12,16-tetramethyl-15-(6-methyl-5-oxoheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl acetate
(1s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-1,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate
(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r)-4-[(2s)-3,3-dimethyloxiran-2-yl]butan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
[(4as,6ar,6bs,8as,9r,12as,12bs,14as,14bs)-2,2,6a,8a,9,12b,14a-heptamethyl-10-oxo-tetradecahydro-1h-picen-4a-yl]methyl acetate
(3s,6r,8s,11r,12s,15s,16r,19s,21s)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl acetate
(2e)-n-[(1s,3as,3br,5as,7s,9as,9bs,11as)-9a,11a-dimethyl-1-[(1s)-1-(n-methylformamido)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-n,3,4-trimethylpent-2-enamide
C31H52N2O2 (484.40285719999997)